Jonathan Yates Boxhall

Title: The Innovations of Jonathan Yates Boxhall

Introduction

Jonathan Yates Boxhall is an accomplished inventor based in Loughborough, GB. He has made significant contributions to the field of pharmaceuticals, particularly in the development of novel compounds. His work focuses on creating innovative solutions that can enhance therapeutic options for various medical conditions.

Latest Patents

Jonathan holds a patent for his invention titled "Polymorphs of N-[(6-cyano-2-fluoro)-3-methoxyphenyl)methyl]-3-(methoxymethyl)-1-({4-[(2-oxopyridin-1-yl)methyl]phenyl}methyl)pyrazole-4-carboxamide as kallikrein inhibitors." This invention provides new polymorphs of the compound, pharmaceutical compositions containing them, and their use in therapy. His patent represents a significant advancement in the search for effective kallikrein inhibitors.

Career Highlights

Jonathan is currently associated with Kalvista Pharmaceuticals Limited, where he continues to push the boundaries of pharmaceutical innovation. His work has been instrumental in developing new therapeutic agents that can potentially improve patient outcomes.

Collaborations

Throughout his career, Jonathan has collaborated with notable colleagues, including Haydn Beaton and David Malcolm Crowe. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and expertise.

Conclusion

Jonathan Yates Boxhall's contributions to the field of pharmaceuticals through his innovative patents and collaborations highlight his commitment to advancing medical science. His work continues to pave the way for new therapeutic possibilities.